Fig. 3From: Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report a–f Representative fluorescence micrographs of platelet poor plasma from Type 2 Diabetes Mellitus (T2DM) patientsBack to article page